Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20022616
Conclusion of this study
Clinical response to Cr is more likely in insulin-resistant subjects who have more elevated fasting glucose and A(1c) levels. Chromium may reduce myocellular lipids and enhance insulin sensitivity in subjects with type 2 diabetes mellitus who do respond clinically independent of effects on weight or hepatic glucose production. Thus, modulation of lipid metabolism by Cr in peripheral tissues may represent a novel mechanism of action.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
Digestive System |
Endocrine System |